mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
0.02 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.03 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.03 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.56 |
0.04 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.04 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.04 |
mRNA |
BI-2536 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.05 |